{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:49:37Z","timestamp":1791571777399,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K23005"],"award-info":[{"award-number":["20K23005"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12771"],"award-info":[{"award-number":["24K12771"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K27750"],"award-info":[{"award-number":["23K27750"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japanese Retinitis Pigmentosa Society (JRPS) Research Grant"},{"name":"Takayanagi Retina Research Award"},{"name":"Medical Research Grant from the Nasu Foundation"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0109707h0001"],"award-info":[{"award-number":["24ek0109707h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ek0109632"],"award-info":[{"award-number":["JP23ek0109632"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"DOI":"10.1038\/s41525-025-00541-0","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:44:51Z","timestamp":1765007091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics of EYS-associated retinal dystrophy in 291 Japanese patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Yoshito","family":"Koyanagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kominami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoruko","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohta","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanayo","family":"Yamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Hisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Nakazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Hirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji M.","family":"Nishiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"541_CR1","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet 368, 1795\u20131809 (2006).","journal-title":"Lancet"},{"key":"541_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.preteyeres.2013.08.001","volume":"37","author":"Y Murakami","year":"2013","unstructured":"Murakami, Y. et al. Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog. Retin Eye Res 37, 114\u2013140 (2013).","journal-title":"Prog. Retin Eye Res"},{"key":"541_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.preteyeres.2017.08.004","volume":"62","author":"PA Campochiaro","year":"2018","unstructured":"Campochiaro, P. A. & Mir, T. A. The mechanism of cone cell death in Retinitis Pigmentosa. Prog. Retin Eye Res. 62, 24\u201337 (2018).","journal-title":"Prog. Retin Eye Res."},{"key":"541_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","volume":"63","author":"MF Dias","year":"2018","unstructured":"Dias, M. F. et al. Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives. Prog. Retin Eye Res. 63, 107\u2013131 (2018).","journal-title":"Prog. Retin Eye Res."},{"key":"541_CR5","unstructured":"RetNet. https:\/\/retnet.org\/; accessed August 23 (2024)."},{"key":"541_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.61.10.6","volume":"61","author":"Y Koyanagi","year":"2020","unstructured":"Koyanagi, Y. et al. Relationship between macular curvature and common causative genes of Retinitis Pigmentosa in Japanese patients. Invest Ophthalmol. Vis. Sci. 61, 6 (2020).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"541_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06534-6","author":"S Nakamura","year":"2024","unstructured":"Nakamura, S. et al. Relationships between causative genes and epiretinal membrane formation in Japanese patients with retinitis pigmentosa. Graefes Arch. Clin. Exp. Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-024-06534-6 (2024).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"541_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","volume":"120","author":"N Yoshida","year":"2013","unstructured":"Yoshida, N. et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120, 100\u2013105 (2013).","journal-title":"Ophthalmology"},{"key":"541_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26231-9","volume":"8","author":"K Fujiwara","year":"2018","unstructured":"Fujiwara, K. et al. Assessment of Central visual function in patients with Retinitis Pigmentosa. Sci. Rep. 8, 8070 (2018).","journal-title":"Sci. Rep."},{"key":"541_CR10","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1111\/aos.13475","volume":"96","author":"Y Koyanagi","year":"2018","unstructured":"Koyanagi, Y. et al. Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa. Acta Ophthalmol. 96, e59\u2013e67 (2018).","journal-title":"Acta Ophthalmol."},{"key":"541_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1167\/iovs.17-23050","volume":"59","author":"Y Murakami","year":"2018","unstructured":"Murakami, Y. et al. Relations among foveal blood flow, retinal-choroidal structure, and visual function in Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 59, 1134\u20131143 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"541_CR12","doi-asserted-by":"publisher","first-page":"e0226097","DOI":"10.1371\/journal.pone.0226097","volume":"14","author":"J Funatsu","year":"2019","unstructured":"Funatsu, J. et al. Direct comparison of retinal structure and function in retinitis pigmentosa by co-registering microperimetry and optical coherence tomography. PLoS One 14, e0226097 (2019).","journal-title":"PLoS One"},{"key":"541_CR13","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1167\/iovs.19-26927","volume":"60","author":"M Ishizu","year":"2019","unstructured":"Ishizu, M. et al. Relationships between serum antioxidant and oxidant statuses and visual function in Retinitis Pigmentosa. Invest Ophthalmol. Vis. Sci. 60, 4462\u20134468 (2019).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"541_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00417-019-04307-0","volume":"257","author":"S Nakatake","year":"2019","unstructured":"Nakatake, S. et al. Early detection of cone photoreceptor cell loss in retinitis pigmentosa using adaptive optics scanning laser ophthalmoscopy. Graefes Arch. Clin. Exp. Ophthalmol. 257, 1169\u20131181 (2019).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"541_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.61.8.26","volume":"61","author":"K Fujiwara","year":"2020","unstructured":"Fujiwara, K. et al. Aqueous flare and progression of visual field loss in patients with Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 61, 26 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"541_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.61.11.30","volume":"61","author":"A Okita","year":"2020","unstructured":"Okita, A. et al. Changes of serum inflammatory molecules and their relationships with visual function in Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 61, 30 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"541_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.oret.2021.12.010","volume":"6","author":"S Nakamura","year":"2022","unstructured":"Nakamura, S. et al. Long-term outcomes of cataract surgery in patients with Retinitis Pigmentosa. Ophthalmol. Retin. 6, 268\u2013272 (2022).","journal-title":"Ophthalmol. Retin."},{"key":"541_CR18","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1097\/IAE.0000000000003589","volume":"42","author":"S Okado","year":"2022","unstructured":"Okado, S. et al. Assessments of macular function by focal macular Electroretinography and static perimetry in eyes with Retinitis Pigmentosa. Retina 42, 2184\u20132193 (2022).","journal-title":"Retina"},{"key":"541_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/IAE.0000000000003286","volume":"42","author":"S Shimokawa","year":"2022","unstructured":"Shimokawa, S. et al. Recurrence rate of cystoid macular Edema with Topical Dorzolamide treatment and its risk factors in Retinitis Pigmentosa. Retina 42, 168\u2013173 (2022).","journal-title":"Retina"},{"key":"541_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/bjophthalmol-2018-312225","volume":"103","author":"KM Nishiguchi","year":"2019","unstructured":"Nishiguchi, K. M., Yokoyama, Y., Kunikata, H., Abe, T. & Nakazawa, T. Correlation between aqueous flare and residual visual field area in retinitis pigmentosa. Br. J. Ophthalmol. 103, 475\u2013480 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"541_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep33248","volume":"6","author":"M Carrigan","year":"2016","unstructured":"Carrigan, M. et al. Panel-based population next-generation sequencing for inherited retinal degenerations. Sci. Rep. 6, 33248 (2016).","journal-title":"Sci. Rep."},{"key":"541_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jmedgenet-2016-103837","volume":"53","author":"JM Ellingford","year":"2016","unstructured":"Ellingford, J. M. et al. Molecular findings from 537 individuals with inherited retinal disease. J. Med. Genet. 53, 761\u2013767 (2016).","journal-title":"J. Med. Genet."},{"key":"541_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","volume":"100","author":"KJ Carss","year":"2017","unstructured":"Carss, K. J. et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am. J. Hum. Genet. 100, 75\u201390 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"541_CR24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","volume":"124","author":"EM Stone","year":"2017","unstructured":"Stone, E. M. et al. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology 124, 1314\u20131331 (2017).","journal-title":"Ophthalmology"},{"key":"541_CR25","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.preteyeres.2025.101391","volume":"108","author":"JP Marques","year":"2025","unstructured":"Marques, J. P. et al. Eyes shut homolog (EYS): Connecting molecule to disease. Prog. Retin Eye Res. 108, 101391 (2025).","journal-title":"Prog. Retin Eye Res."},{"key":"541_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10384-018-0601-x","volume":"62","author":"A Maeda","year":"2018","unstructured":"Maeda, A. et al. Development of a molecular diagnostic test for Retinitis Pigmentosa in the Japanese population. Jpn J. Ophthalmol. 62, 451\u2013457 (2018).","journal-title":"Jpn J. Ophthalmol."},{"key":"541_CR27","doi-asserted-by":"publisher","first-page":"20770","DOI":"10.1038\/s41598-020-77558-1","volume":"10","author":"S Numa","year":"2020","unstructured":"Numa, S. et al. EYS is a major gene involved in retinitis pigmentosa in Japan: genetic landscapes revealed by stepwise genetic screening. Sci. Rep. 10, 20770 (2020).","journal-title":"Sci. Rep."},{"key":"541_CR28","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/humu.24492","volume":"43","author":"A Suga","year":"2022","unstructured":"Suga, A. et al. Genetic characterization of 1210 Japanese pedigrees with inherited retinal diseases by whole-exome sequencing. Hum. Mutat. 43, 2251\u20132264 (2022).","journal-title":"Hum. Mutat."},{"key":"541_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/jmg-2023-109750","volume":"61","author":"K Goto","year":"2024","unstructured":"Goto, K. et al. Disease-specific variant interpretation highlighted the genetic findings in 2325 Japanese patients with retinitis pigmentosa and allied diseases. J. Med. Genet. 61, 613\u2013620 (2024).","journal-title":"J. Med. Genet."},{"key":"541_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/ng.241","volume":"40","author":"MM Abd El-Aziz","year":"2008","unstructured":"Abd El-Aziz, M. M. et al. EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa. Nat. Genet. 40, 1285\u20131287 (2008).","journal-title":"Nat. Genet."},{"key":"541_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ajhg.2008.10.014","volume":"83","author":"RW Collin","year":"2008","unstructured":"Collin, R. W. et al. Identification of a 2 Mb human ortholog of Drosophila eyes shut\/spacemaker that is mutated in patients with retinitis pigmentosa. Am. J. Hum. Genet. 83, 594\u2013603 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"541_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.oret.2023.02.001","volume":"7","author":"RM Soares","year":"2023","unstructured":"Soares, R. M. et al. Eyes shut Homolog-associated retinal degeneration: natural history, genetic landscape, and phenotypic spectrum. Ophthalmol. Retin. 7, 628\u2013638 (2023).","journal-title":"Ophthalmol. Retin."},{"key":"541_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/ceo.13458","volume":"47","author":"M Iftikhar","year":"2019","unstructured":"Iftikhar, M. et al. Progression of retinitis pigmentosa on multimodal imaging: The PREP-1 study. Clin. Exp. Ophthalmol. 47, 605\u2013613 (2019).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"541_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.oret.2021.02.009","volume":"5","author":"Y Murakami","year":"2021","unstructured":"Murakami, Y. et al. Genotype and long-term clinical course of Bietti crystalline dystrophy in Korean and Japanese patients. Ophthalmol. Retin. 5, 1269\u20131279 (2021).","journal-title":"Ophthalmol. Retin."},{"key":"541_CR35","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ophtha.2019.05.027","volume":"126","author":"KM Nishiguchi","year":"2019","unstructured":"Nishiguchi, K. M. et al. Phenotypic features of Oguchi disease and Retinitis Pigmentosa in patients with S-antigen mutations: a long-term follow-up study. Ophthalmology 126, 1557\u20131566 (2019).","journal-title":"Ophthalmology"},{"key":"541_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747\u2013753 (2009).","journal-title":"Nature"},{"key":"541_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10384-025-01179-2","volume":"69","author":"Y Murakami","year":"2025","unstructured":"Murakami, Y. et al. Study protocol for a prospective natural history registry investigating the relationships between inflammatory markers and disease progression in retinitis pigmentosa: the RP-PRIMARY study. Jpn J. Ophthalmol. 69, 378\u2013386 (2025).","journal-title":"Jpn J. Ophthalmol."},{"key":"541_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10384-021-00824-w","volume":"65","author":"Y Koyanagi","year":"2021","unstructured":"Koyanagi, Y. et al. Regional differences in genes and variants causing retinitis pigmentosa in Japan. Jpn J. Ophthalmol. 65, 338\u2013343 (2021).","journal-title":"Jpn J. Ophthalmol."},{"key":"541_CR39","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.1167\/iovs.11-7292","volume":"52","author":"JI Pieras","year":"2011","unstructured":"Pieras, J. I. et al. Copy-number variations in EYS: a significant event in the appearance of arRP. Invest. Ophthalmol. Vis. Sci. 52, 5625\u20135631 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"541_CR40","doi-asserted-by":"publisher","first-page":"e78496","DOI":"10.1371\/journal.pone.0078496","volume":"8","author":"T Eisenberger","year":"2013","unstructured":"Eisenberger, T. et al. Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One 8, e78496 (2013).","journal-title":"PLoS One"},{"key":"541_CR41","doi-asserted-by":"publisher","first-page":"16139","DOI":"10.1073\/pnas.1308243110","volume":"110","author":"KM Nishiguchi","year":"2013","unstructured":"Nishiguchi, K. M. et al. Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. Proc. Natl. Acad. Sci. USA 110, 16139\u201316144 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"541_CR42","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1002\/ajmg.a.40668","volume":"176","author":"O Wormser","year":"2018","unstructured":"Wormser, O. et al. Combined CNV, haplotyping and whole exome sequencing enable identification of two distinct novel EYS mutations causing RP in a single inbred tribe. Am. J. Med Genet. A 176, 2695\u20132703 (2018).","journal-title":"Am. J. Med Genet. A"},{"key":"541_CR43","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1136\/jmedgenet-2022-108428","volume":"59","author":"Y Sano","year":"2022","unstructured":"Sano, Y. et al. Likely pathogenic structural variants in genetically unsolved patients with retinitis pigmentosa revealed by long-read sequencing. J. Med. Genet. 59, 1133\u20131138 (2022).","journal-title":"J. Med. Genet."},{"key":"541_CR44","doi-asserted-by":"crossref","unstructured":"Fernandez-Suarez, E. et al. Long-read sequencing improves the genetic diagnosis of retinitis pigmentosa by identifying an Alu retrotransposon insertion in the EYS gene. Mob. DNA 15, 9 (2024).","DOI":"10.1186\/s13100-024-00320-1"},{"key":"541_CR45","doi-asserted-by":"publisher","first-page":"e0305812","DOI":"10.1371\/journal.pone.0305812","volume":"19","author":"M Hiraoka","year":"2024","unstructured":"Hiraoka, M. et al. Copy number variant detection using next-generation sequencing in EYS-associated retinitis pigmentosa. PLoS One 19, e0305812 (2024).","journal-title":"PLoS One"},{"key":"541_CR46","doi-asserted-by":"publisher","first-page":"e31036","DOI":"10.1371\/journal.pone.0031036","volume":"7","author":"K Hosono","year":"2012","unstructured":"Hosono, K. et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One 7, e31036 (2012).","journal-title":"PLoS One"},{"key":"541_CR47","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1167\/iovs.14-15458","volume":"55","author":"M Oishi","year":"2014","unstructured":"Oishi, M. et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest. Ophthalmol. Vis. Sci. 55, 7369\u20137375 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"541_CR48","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/jmedgenet-2018-105691","volume":"56","author":"Y Koyanagi","year":"2019","unstructured":"Koyanagi, Y. et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J. Med. Genet. 56, 662\u2013670 (2019).","journal-title":"J. Med. Genet."},{"key":"541_CR49","doi-asserted-by":"crossref","unstructured":"Nishiguchi, K. M. et al. A hypomorphic variant in EYS detected by genome-wide association study contributes toward retinitis pigmentosa. Commun. Biol. 4, 140 (2021).","DOI":"10.1038\/s42003-021-01662-9"},{"key":"541_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archopht.1994.01090150059023","volume":"112","author":"IU Scott","year":"1994","unstructured":"Scott, I. U. et al. Functional status and quality of life measurement among ophthalmic patients. Arch. Ophthalmol. 112, 329\u2013335 (1994).","journal-title":"Arch. Ophthalmol."},{"key":"541_CR51","unstructured":"International Council of Ophthalmology (ICO). Visual acuity measurement standard. Kos, Greece: ICO (1984)."},{"key":"541_CR52","doi-asserted-by":"crossref","unstructured":"Suto, K. et al. Clinical phenotype in ten unrelated Japanese patients with mutations in the EYS gene. Ophthalmic Genet. 35, 25\u201334 (2014).","DOI":"10.3109\/13816810.2013.768673"},{"key":"541_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17, 405\u2013424 (2015).","journal-title":"Genet Med."},{"key":"541_CR54","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"541_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"541_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"541_CR57","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkad978","volume":"52","author":"S Tadaka","year":"2024","unstructured":"Tadaka, S. et al. jMorp: Japanese Multi-Omics Reference Panel update report 2023. Nucleic Acids Res. 52, D622\u2013D632 (2024).","journal-title":"Nucleic Acids Res."},{"key":"541_CR58","doi-asserted-by":"publisher","first-page":"eaaz7835","DOI":"10.1126\/sciadv.aaz7835","volume":"6","author":"S Jeon","year":"2020","unstructured":"Jeon, S. et al. Korean Genome Project: 1094 Korean personal genomes with clinical information. Sci. Adv. 6, eaaz7835 (2020).","journal-title":"Sci. Adv."},{"key":"541_CR59","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1167\/iovs.10-7108","volume":"52","author":"Q Fan","year":"2011","unstructured":"Fan, Q., Teo, Y. Y. & Saw, S. M. Application of advanced statistics in ophthalmology. Invest. Ophthalmol. Vis. Sci. 52, 6059\u20136065 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"541_CR60","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.ophtha.2014.07.017","volume":"121","author":"D Jinapriya","year":"2014","unstructured":"Jinapriya, D. et al. Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 121, 2356\u20132361 (2014).","journal-title":"Ophthalmology"},{"key":"541_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.13.10.15","volume":"13","author":"MG Maguire","year":"2024","unstructured":"Maguire, M. G. et al. Endpoints and design for clinical trials in USH2A-related retinal degeneration: results and recommendations from the RUSH2A Natural History Study. Transl. Vis. Sci. Technol. 13, 15 (2024).","journal-title":"Transl. Vis. Sci. Technol."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00541-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00541-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00541-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:03:35Z","timestamp":1767801815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00541-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1038\/s41525-025-00541-0","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yoshito Koyanagi received research grants from the Japanese Retinitis Pigmentosa Society (JRPS), the Takayanagi Retina Research Award, and the Nasu Foundation. Satoshi Yokota received research grants (to Kobe City Eye Hospital) from the Japan Agency for Medical Research and Development (AMED; JP21bk0104118h0001), Santen Pharmaceutical Co., Ltd., and Vision Care Inc. Yuji Inoue received lecture fees from Novartis Pharmaceuticals. Takaaki Hayashi received a grant from the Japan Society for the Promotion of Science (KAKENHI Grant No. 24K12771). Yasuhiko Hirami received grants (to Kobe City Eye Hospital) from the Japan Agency for Medical Research and Development (AMED; JP21bk0104118h0001), Santen Pharmaceutical Co., Ltd., and Vision Care Inc. Masato Akiyama received grants from Novartis Pharma K.K. (for glaucoma research), Santen Pharmaceutical Co., Ltd. (for ocular tumor research), and Alcon (for ocular tumor research). He reported consulting fees for genetic testing for IRD from Sysmex. Furthermore, honoraria for lectures were received from Novartis Pharma K.K., Takeda Pharma Ltd., Senju Pharmaceutical Co., Ltd., Chugai Pharmaceutical Corporation, Kowa Co. Ltd., Chugai Pharmaceutical, Bayer Yakuhin, and Santen Pharmaceutical Corporation. He received support for attending meetings and travel from WAKAMOTO PHARMACEUTICAL CO. LTD., Novartis Pharma K.K. and Chugai Pharmaceutical. He is an endowed faculty member supported by NIDEK Co. Ltd. Koh-Hei Sonoda received grants (to his department) from Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., HOYA Co., Ltd., WAKAMOTO Pharmaceutical Co., Ltd., AMO Japan K.K., Kowa Company, Ltd., Alcon Japan Ltd, Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., Senju Pharmaceutical Corporation, and Sand Corporation. He received consulting fees from Santen Pharmaceutical Corporation, Senju Pharmaceutical Corporation, Japan Tobacco Inc., Chugai Pharmaceutical Corporation, Sand Corporation, and Riverfield Corporation. He received payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from AMO Japan K.K., Novartis Pharma K.K., WAKAMOTO Pharmaceutical Co., Ltd., NIDEK CO., LTD., Canon Marketing Japan Inc., TOPCON CO., LTD., Senju Pharmaceutical Corporation, Santen Pharmaceutical Corporation, Chugai Pharmaceutical Corporation, Bayer Corporation, Alcon Japan Ltd, Eisai Corporation, Otsuka Pharmaceutical Corporation, Ono Pharmaceutical Company Limited, Canon Marketing Japan, Viatoris Pharmaceutical Co., Ltd, and Celltrion Healthcare Japan K.K. Koji M. Nishiguchi received funding from JCR Pharma Ltd for\n                      EYS\n                      gene therapy research, paid to his institution. He is a co-inventor of a pending patent (application number: 2022-030349) filed by National University Corporation Tokai National Higher Education and Research. The patent application, which is currently pending, pertains to gene therapy for the S1653Kfs mutation, an aspect discussed in the manuscript. Yasuhiro Ikeda received a grant from the Japan Agency for Medical Research and Development (JP23ek0109632). Yusuke Murakami, Taro Kominami, Masatoshi Fukushima, Kensuke Goto, Kei Mizobuchi, Go Mawatari, Kaoruko Torii, Junya Ota, Daishi Okuda, Kohta Fujiwara, Hanayo Yamaga, Takahiro Hisai, Mikiko Endo, Hanae Iijima, Tomoko Kaida, Kazunori Miyata, Shuji Nakazaki, Chikashi Terao, and Yukihide Momozawa declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}